Australian doctors are claiming positive results after trialling a new class of drugs on late stage prostate cancer. The disease is difficult to treat, and 3,200 Australian men still die of prostate cancer each year.
The trial uses two drugs.
One is a promising new cancer drug Lutetium P-S-M-A, which is injected intravenously to deliver a small amount of radioactivity to tumour cells.
The second trial drug, called Veyonda, was developed by Australian doctor Graham Kelly.
Click on the image above to listen to this feature.
Listen to SBS Indonesian every Monday, Wednesday, Friday and Sunday at 3 pm.
Follow us on Facebook and catch us on podcasts.
Share
